Morisada Hayakawa - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Morisada Hayakawa

Showing results (31-40 of 35) with videos related to

Pageof 4

Sort By:

You have reached the last page of results.This site can display upto 35 results.

Molecular Therapy. Methods & Clinical Development|September 11, 2023

Efficient gene transduction in pigs and macaques with the engineered AAV vector AAV.GT5 for hemophilia B gene therapyYuji Kashiwakura, Kazuhiro Endo, Atsushi Ugajin, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018

Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of MacrophagesKent Sakai, Shuichi Nagashima, Tetsuji Wakabayashi, et al.

Molecular Cell|December 13, 2006

SNIP1 is a candidate modifier of the transcriptional activity of c-Myc on E box-dependent target genesMakiko Fujii, Lyudmila A Lyakh, Cameron P Bracken, et al.

Transplantation|August 29, 2019

Alloreactive T Cells Display a Distinct Chemokine Profile in Response to Conditioning in Xenogeneic GVHD ModelsYasufumi Kawasaki, Kazuya Sato, Hirofumi Nakano, et al.

Molecular Therapy. Methods & Clinical Development|November 16, 2022

The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacsYuji Kashiwakura, Nemekhbayar Baatartsogt, Shoji Yamazaki, et al.

Pageof 4

Search research articles

Showing results (31-40 of 35) with videos related to

Sort By:

Pageof 4

You have reached the last page of results.This site can display upto 35 results.

Molecular Therapy. Methods & Clinical Development|September 11, 2023

Efficient gene transduction in pigs and macaques with the engineered AAV vector AAV.GT5 for hemophilia B gene therapyYuji Kashiwakura, Kazuhiro Endo, Atsushi Ugajin, et al.

Arteriosclerosis, Thrombosis, and Vascular Biology|October 26, 2018

Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of MacrophagesKent Sakai, Shuichi Nagashima, Tetsuji Wakabayashi, et al.

Molecular Cell|December 13, 2006

SNIP1 is a candidate modifier of the transcriptional activity of c-Myc on E box-dependent target genesMakiko Fujii, Lyudmila A Lyakh, Cameron P Bracken, et al.

Transplantation|August 29, 2019

Alloreactive T Cells Display a Distinct Chemokine Profile in Response to Conditioning in Xenogeneic GVHD ModelsYasufumi Kawasaki, Kazuya Sato, Hirofumi Nakano, et al.

Molecular Therapy. Methods & Clinical Development|November 16, 2022

The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacsYuji Kashiwakura, Nemekhbayar Baatartsogt, Shoji Yamazaki, et al.

Pageof 4